Alison M. McDonnell - Concepedia

Author

Alison M. McDonnell

The University of Western Australia ORCID

Also Known As

A. McDonnell, A.M. McDonnell, Alison M McDonnell, Alison M. McDonnell, Alison McDonnell, McDonnell, Alison

Publications

875

Citations

H-Index

Concepts

All Affiliations

The University of Western Australia Sir Charles Gairdner Hospital Murdoch University The Kids Research Institute Australia Asbestos Diseases Research Institute

About

Alison M. McDonnell is an author at The University of Western Australia specializing in immunology, medicine, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	259
2	Immunology	5	5	259
3	Cell Biology	3	3	129
4	Pathology	2	2	168
5	Autoimmunity	2	2	106

Alison M. McDonnell

Publications

690

Citations

H-Index

Page 1

	Year	Citations
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma Anna K. Nowak, Alistair Cook, Alison M. McDonnell, Annals of Oncology Phase 1BMalignant Pleural MesotheliomaMedicineCd40-activating Antibody Cp-870,893Immunology	2015	98
Tumor‐infiltrating dendritic cells exhibit defective cross‐presentation of tumor antigens, but is reversed by chemotherapy Alison M. McDonnell, W. Joost Lesterhuis, Andrea Khong, European Journal of Immunology	2014	92
Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy Nicola Principe, Joel Kidman, Siting Goh, Frontiers in Immunology	2020	84
Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies Alistair Cook, Alison M. McDonnell, Richard Lake, OncoImmunology	2015	75
Tumor Antigen Cross‐Presentation and the Dendritic Cell: Where it All Begins? Alison M. McDonnell, B. W. Robinson, Andrew Currie Journal of Immunology Research Dendritic CellImmunologyPathologyAntigen ProcessingImmunotherapeutics	2010	70
Dual Control of Antitumor CD8 T Cells through the Programmed Death-1/Programmed Death-Ligand 1 Pathway and Immunosuppressive CD4 T Cells: Regulation and Counterregulation Andrew Currie, Amy Prosser, Alison M. McDonnell, The Journal of Immunology	2009	56
CD8α<sup>+</sup> DC are not the sole subset cross‐presenting cell‐associated tumor antigens from a solid tumor Alison M. McDonnell, Amy Prosser, Ivonne van Bruggen, European Journal of Immunology Dc SubsetsImmunologyAntigen ProcessingSolid TumorImmunotherapy	2010	36
PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitors Tarek Meniawy, Richard Lake, Alison M. McDonnell, Lung Cancer Cancer ImmunosurveillanceMedicineImmunologyPeripheral Blood TEgfr Inhibitors	2015	32
Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors Sarah Dart, Alistair Cook, Michael Millward, Scientific Reports	2021	24
Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation Alison M. McDonnell, Andrew Currie, Matthew D. Brown, OncoImmunology ImmunologyImmunoeditingTumor CellsAntigen ProcessingImmunotherapy	2012	23

Page 1